Back to Rankings

ACAD

ACADIAA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ACAD vs peer average
80/100
ACAD vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 3 · D 4
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

OGN is the first available peer comparator.

Similar-sized commercial pharma with existing marketed products; useful for comparing execution, margins, and launch durability, though therapeutic overlap is limited.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerOGNOrganon
ACAD
ACADIA
OGN
Organon
Grade
A
B
Momentum
74
63
Value
62
71
Sentiment
48
42
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs OGN

ACAD / OGN
Grade Position
Above peers
ACAD vs. peer average (A vs. C)
80/100
Momentum
74
ACAD
Value
62
OGN
Sentiment
48
ACAD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ACAD
1
OGN
OGN
A
100/100
Even
2
CRNX
CRNX
D
40/100
+3
3
VKTX
Viking Therapeutics Inc Common
B
80/100
+1
4
EWTX
Edgewise Therapeutics Inc Common
C
60/100
+2
5
DNLI
Denali Therapeutics Inc Common
C
60/100
+2
OGN is the first peer returned for this comparison set.